C. Piguet, P.-Y. Morgantini et al.
Preparation of 2,6-bis-(1-ethyl-5-carboxybenzimidazol-2-yl)pyridine (3):
Compound 2 (0.40 g, 0.83 mmol) and KOH (1.00 g, 17.82 mmol) were re-
fluxed in ethanol/water (50 mL:20 mL) for 45 min. The hot solution was
neutralized with conc. hydrochloric acid (35%) until pH 1.0, and a white
precipitate formed upon cooling. The precipitate was filtered and dried
under vacuum (908C) to give 0.38 g (0.83 mmol, yield 100%) of 3 as a
white solid. 1H NMR ([D6]DMSO): d=1.29 (t, J3 =7 Hz, 6H), 4.82 (q,
J3 =7 Hz, 4H), 7.84 (d, J3 =7 Hz, 2H), 7.96 (dd, J3 =8 Hz, J4 =1 Hz, 2H),
8.22–8.35 (m, 3H), 8.40 ppm (d, J3 =8 Hz, 2H); 13C NMR ([D6]DMSO):
d=15.64 (Cprim); 40.47 (Csec); 111.76, 122.15, 125.12, 126.78, 139.59 (Ctert);
125.94, 139.53, 142.53, 149.84, 151.72, 168.35 ppm (Cquat); EI-MS: m/z:
455 [M]+.
3.91 (m, 6H), 5.17 (m, 1H), 6.05 ppm (s, 2H); 13C NMR (CDCl3): d=
14.14 (Cprim); 22.73, 26.12, 26.18, 29.36, 29.41, 29.43, 29.46, 29.67, 29.69,
29.74, 29.77, 29.79, 30.27, 31.75, 31.96, 68.98, 73.69 (Csec); 94.25 (Ctert);
131.89, 151.89, 153.54 ppm (Cquat); EI-MS: m/z: 647 [M]+. The same pro-
cedure was followed for the derivatives 6C1 and 6C0
.
1
Data for 6Cl: H NMR (CDCl3): d=3.70 (s, 9H), 5.25 (brs, 1H), 6.05 ppm
(s, 2H); 13C NMR (CDCl3): d=56.30 (Cprim); 94.10 (Ctert); 132.10, 151.65,
154.20 (Cquat); EI-MS: m/z: 185 [M+].
1
Data for 6C0: H NMR (CDCl3): d=5.40 (brs, 4H), 6.12 ppm (s, 2H); EI-
MS: m/z: 143 [M+].
Preparation of 2,6-bis-(1-ethyl-5-carboxybenzimidazol-2-yl)pyridine-
di[3,4,5-tris(alkyloxy)benzyl] ester (L5Cn
; n=0, 1, 12): A catalytic
Preparation of 3,4,5-trialkoxybenzyl methyl ester (4Cn, n=1, 12): Com-
pound 4C0 (8.00 g, 43.4 mmol), anhydrous potassium carbonate (54.17 g,
391.9 mmol), 1-bromododecane (38.37 g, 130.3 mmol) and potassium
iodide (200 mg, 1.20 mmol) were refluxed in dry acetone (300 mL) for
2 d. The solution was evaporated to dryness, partitioned between di-
chloromethane (200 mL) and water (200 mL). The organic layer was sep-
arated, and the aqueous phase extracted with dichloromethane (3
200 mL). The combined organic phases were dried (Na2SO4), filtered,
and evaporated to give a colorless oil, which was triturated with ethanol
(50 mL). The resulting voluminous white solid residue was filtered and
dried under vacuum to give 15.27 g (22.15 mmol, yield 51%) of 4C12 as a
white solid. M.p.=458C; 1H NMR (CDCl3): d=0.91 (t, J3 =7 Hz, 18H),
1.24–1.42 (m, 48H), 1.46–1.53 (m, 6H), 1.75–1.87 (m, 6H), 3.91 (s, 3H),
4.02–4.05 (m, 6H), 7.27 ppm (s, 2H); 13C NMR (CDCl3): d=14.11 , 50.09
(Cprim); 22.70 , 26.08, 26.10, 29.34, 29.37, 29.41, 29.58, 29.65, 29.67, 29.71,
29.74, 29.76, 30.35, 31.94, 31.95, 69.22, 73.51 (Csec); 108.08 (Ctert); 124.67,
142.46, 152.84, 166.95 ppm (Cquat); EI-MS: m/z: 688 [M]+. The same pro-
cedure was followed for the derivative 4C1 by using methyliodide as the
alkylating agent.
amount of 4-dimethylaminopyridine, compound 3 (0.21 g, 0.46 mmol),
compound 6C12 (0.60 g, 0.93 mmol), and EDCI (0.36 g, 1.85 mmol) were
refluxed for 6 h in CH2Cl2 (50 mL) under an inert atmosphere. The re-
sulting mixture was washed with water (4100 mL). The organic layer
was separated, dried (Na2SO4), and evaporated to dryness. The crude
yellow oil was purified by column chromatography (silica gel; CH2Cl2/
MeOH 100:0!99:1) to give 0.56 g (0.33 mmol, yield 71%) of L5C12 as a
pale yellow solid. 1H NMR (CDCl3): d=0.82–0.86 (m, 18H), 1.23–1.40
(m, 114H), 1.69–1.86 (m, 12H), 3.91–3.96 (m, 12H), 4.83 (q, J3 =7.2 Hz,
4H), 6.45 (s, 4H), 7.54 (d, J3 =8.7 Hz, 2H), 8.10 (t, J3 =7.8 Hz, 1H), 8.20
(dd, J3 =8.7 Hz, J4 =1.5 Hz, 2H), 8.40 (d, J3 =7.8 Hz, 2H), 8.72 ppm (d,
J4 =1.5 Hz, 2H); 13C NMR (CDCl3): d=14.32, 15.69 (Cprim); 14.32, 15.69,
22.89, 26.29, 26.36, 29.50, 29.57, 29.61, 29.85, 29.90, 29.98, 30.55, 32.13,
32.15, 40.43, 69.31, 73.73 (Csec); 100.54, 110.37, 123.73, 125.69, 126.59,
138.69 (Ctert); 124.60, 136.03, 139.76, 142.75, 146.95, 149.82, 151.85,
153.57, 165.88 ppm (Cquat); ESI-MS (CH2Cl2/MeOH 9:1 + HCl 0.1%):
m/z: 1714.4
[M+H]+; elemental analysis calcd (%)
for
C109H173N5O10·0.6H2O (1724.40): C 75.90, H 10.10, N 4.06; found: C
75.61, H 10.26, N 3.94; the same procedure was followed for the ligands
Data for 4Cl 1H NMR (CDCl3): d=3.88 (s, 9H), 3.91 (s, 3H), 7.33 ppm
:
L5C1 and L5C0
Data for L5C1
.
(s, 2H); 13C NMR (CDCl3): d=56.42, 61.14 (Cprim); 107.56 (Ctert); 124.32,
143.13, 153.14, 166.95 ppm (Cquat); EI-MS: m/z: 226 [M+].
:
1H NMR (CDCl3): d=1.39 (t, J3 =7.2 Hz, 6H), 3.85 (s,
18H), 4.84 (q, J3 =6.7 Hz, 4H), 6.50 (s, 4H), 7.55 (d, J3 =8.7 Hz, 2H),
8.10 (t, J3 =7.8 Hz, 1H), 8.20 (dd, J3 =8.7 Hz, J4 =1.5 Hz, 2H), 8.40 (d,
J3 =7.8 Hz, 2H), 8.73 ppm (d, J4 =1.5 Hz, 2H); 13C NMR (CDCl3): d=
15.68, 56.39, 61.15 (Cprim); 40.44 (Csec); 99.58, 110.42, 123.76, 125.70,
126.61, 138.68 (Ctert); 124.41, 136.05, 139.84, 142.78, 147.43, 149.82,
151.89, 153.77, 165.87 ppm (Cquat); ESI-MS (CH2Cl2/MeOH 9:1): m/z:
810.3 [M+Na]+, 1598.2 [2M+Na]+; elemental analysis calcd (%) for
C43H41N5O10·0.6H2O (798.62): C 64.67, H 5.33, N 8.77; found: C 64.70, H
5.41, N 8.77; recrystallization from CH2Cl2/hexane gave X-ray quality
prisms of L5C12·0.5CH2Cl2.
Preparation of 2-(3,4,5-trisdodecyloxyphenyl)propan-2-ol (5Cn, n=0, 1,
12): Methyl iodide (2,27 g, 16.00 mmol) was added to a suspension of
magnesium (0.39 g, 16.00 mmol) in dry diethyl ether (50 mL). The reac-
tion was initiated by heating and then the temperature was controlled
with a water/ice bath. When solid magnesium had disappeared, a solution
of compound 4C12 (5.00 g, 7.26 mmol) in dry diethyl ether (5 mL) was
slowly added. The resulting mixture was refluxed for 12 h. Addition of a
saturated aqueous ammonium chloride solution (10 mL) produced a vigo-
rous reaction, then water (150 mL) and diethyl ether (150 mL) were
added. The organic layer was separated, and the aqueous phase extracted
with diethyl ether (350 mL). The combined organic phases were dried
(Na2SO4), filtered, and evaporated to give a pale yellow oil. Column
chromatography (silica gel; CH2Cl2) gave 4.50 g (6.53 mmol, yield 90%)
of 5C12 as a colorless oil, which was poorly stable at RT. 1H NMR
(CDCl3): d=0.91 (t, J3 =6.9 Hz, 18H), 1.23–1.39 (m, 48H), 1.45–1.53 (m,
6H), 1.58 (s, 6H), 1.73–1.85 (m, 6H), 3.96 (t, J3 =6.6 Hz, 2H), 4.01 (t,
J3 =6.5 Hz, 4H), 6.70 ppm (s, 2H); EI-MS: m/z: 670 [M+]. The same pro-
Data for L5C0 1H NMR (CDCl3): d=1.45 (t, J3 =7.2 Hz, 6H), 4.90 (q,
:
J3 =7.2 Hz, 4H), 7.28–7.40 (m, 6H), 7.47–7.51 (m, 4H), 7.62 (d, J3 =
8.6 Hz, 2H), 8.17 (t, J3 =7.9 Hz, 1H), 8.29 (dd, J3 =8.6 Hz, J4 =1.6 Hz,
2H), 8.48 (d, J3 =7.9 Hz, 2H), 8.82 ppm (d, J4 =1.3 Hz, 2H); 13C NMR
(CDCl3): d=15.51 (Cprim); 40.32 (Csec); 110.30, 121.83, 123.48, 125.68,
125.85, 126.57, 138.59 (Ctert); 124.56, 139.48, 151.19, 151.53, 165.53 ppm
(Cquat); ESI-MS (CH2Cl2/MeOH 9:1): m/z: 608.2 [M]+, 630.2 [M+Na]+,
1214.2 [2M]+, 1237.2 [2M+Na]+; elemental analysis calcd (%) for
C37H29N5O4 (607.67): C 73.13, H 4.81, N 11.52; found: C 73.23, H 4.71, N
11.56.
cedure was followed for the derivatives 5C1 and 5C0
Data for 5Cl 1H NMR (CDCl3): d=1.59 (s, 6H), 3.78 (s, 9H), 6.70 ppm
(s, 2H); EI-MS: m/z: 208 [M+].
.
:
Preparation of (4-hydroxyphenyl)-1-(3,4,5-trimethoxy)benzoic acid ester
(19): A catalytic amount of 4-dimethylaminopyridine, 3,4,5-tri(dodecylox-
y)benzoic acid (3.00 g, 4.44 mmol),[9d] 4-benzyloxyphenol (0.82 g,
4.10 mmol), and dicyclohexylcarbodiimide (DCC, 1.83 g, 8.87 mmol)
were refluxed for 16 h in CH2Cl2 (100 mL). The resulting insoluble dicy-
clohexylurea was separated by filtration and the resulting mixture evapo-
rated to dryness. The colorless oil was purified by column chromatogra-
phy (silica gel; CH2Cl2), then recrystallized from ethanol to give 3.29 g
(3.84 mmol, yield 84%) of (p-benzyloxyphenyl)-1-(3,4,5-trimethoxy)ben-
zoic acid ester as a white solid. M.p.=438C; 1H NMR (CDCl3): d=0.85
(t, J3 =6.9 Hz, 9H), 1.15–1.60 (m, 54H), 1.68–1.84 (m, 6H), 3.98–4.04 (m,
6H), 5.05 (s, 2H), 6.98 (d, J3 =9.3 Hz, 2H), 7.08 (t, J3 =9.3 Hz, 2H), 7.28–
7.44 ppm (m, 7H); 13C NMR (CDCl3): d=14.43 (Cprim); 22.91, 26.29,
29.49, 29.58, 29.61, 29.79, 29.85, 29.87, 29.91, 29.94, 30.55, 32.14, 69.41,
70.61, 73.77 (Csec); 108.65, 115.70, 122.75, 127.70, 128.24, 128.82 (Ctert);
Data for 5C0 1H NMR (CDCl3): d=1.60 (s, 6H), 6.72 ppm (s, 2H); EI-
:
MS: m/z: 166 [M+].
Preparation of 3,4,5-trisdodecyloxyphenol (6Cn , n=0, 1, 12): BF3·Et2O
(2.06 g, 14.50 mmol) and NaBO3·4H2O (0.45 g, 2.90 mmol) were dissolved
in dry THF (20 mL) at 08C. After 30 min stirring at 08C, a solution of
compound 5C12 (1.00 g, 1.45 mmol) in THF (5 mL) was added and the re-
action was left to reach RT, and stirred for a further 12 h. A saturated
aqueous sodium sulfite solution (10 mL) was added together with water
(100 mL). The resulting mixture was extracted with diethyl ether (3
100 mL). The combined organic phases were dried (Na2SO4), filtered,
and evaporated to give a brownish solid. Column chromatography (silica
gel; CH2Cl2) gave 0.76 g (1.17 mmol, yield 81%) of 6C12 as a air-sensitive
pale yellow solid. M.p.=488C; 1H NMR (CDCl3): dH 0.90 (t, J3 =6.9 Hz,
18H), 1.28–1.34 (m, 48H), 1.42–1.46 (m ,6H), 1.70–1.82 (m, 6H), 3.86–
1688
ꢀ 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2007, 13, 1674 – 1691